35
Finn-Medi Campus Innovation Platform for future health and well-beingFastest Growing Life Science Center in Finland

Finn Medi Presentation study visit (Life Sciences Sector)

Embed Size (px)

DESCRIPTION

Description of the FinnMedi company, an internationally operating company located in Finland and providing services related to research commercialization, business development and clinical research in the Life Sciences sector.

Citation preview

Page 1: Finn Medi Presentation study visit (Life Sciences Sector)

Finn-Medi Campus

’Innovation Platform for future health and well-being’

Fastest Growing Life Science Center in Finland

Page 2: Finn Medi Presentation study visit (Life Sciences Sector)

Topics

• Finn-Medi Campus

• FinnMedi Oy

• Future

• Programmes

• Lessions learned

• Contact information

• Questions

Page 3: Finn Medi Presentation study visit (Life Sciences Sector)

18.9.2014

© FinnMedi Oy 3

• A combination of multi-disciplinary, technological, bio-medical and

medical expertise

• Gathers experts and service in education, research, healthcare

and business.

• The most efficient operational environment in Finland, Finn-Medi

campus

• Highest growth in jobs

• New building (7000-10000 m2) every 2. year

• Top science

Fastest Growing

Life Science Center

Page 4: Finn Medi Presentation study visit (Life Sciences Sector)

Milestones

• Establishment of Institute of Biotechnology at 1960’s (multidisciplinary approach)

• First technology center to Tampere, Hermia at 1980’s

• Project plans for Finn-Medi at 1990

• External threat 1992-1994 (closing medical school)

• Center of Expertise project and status at 1994

• Finn-Medi Technology Center and Finn-Medi Research (now FinnMedi Oy) start at 1995

• Next phases for technology center and Center of Expertise project at 1999

• BioneXt Tampere –program 2003-2010

• HealhBio and Wellness Cluster Programmes 2007-2013

• Innovative Cities 2014-2020

Page 5: Finn Medi Presentation study visit (Life Sciences Sector)

Finn-Medi Campus • CLINICAL CORE

• Tampere University Hospital

• 2nd LAYER

• Clinical services

COLLABORATION CIRCLE

• Science and Business Park

• Patient Hotel

• Other services FM8

FM20

Page 6: Finn Medi Presentation study visit (Life Sciences Sector)

18.9.2014

© FinnMedi Oy 6

18.9.2014

© FinnMedi Oy 6

Growth of Finn-Medi Campus

FM 1 1994

FM 3 2001

FM 2 1999

FM 4 2003

FM 5 2004

FM 6-7 2011

COXA 2002

Cancer hospital

2007

TaY 2009

TaY 2015

TAMK 2012

TAYS

2015 ACUTA

2009

TAYS 2013

FM 20-24 2015-

FM 8 2014

Page 7: Finn Medi Presentation study visit (Life Sciences Sector)

Tight Co-operation brings results

• Multidisciplinary co-operation with companies, researchers, investors and other interest groups.

• Parties eg:

– Tampere University Hospital, 4000 employees, 28 clinics

– University of Tampere, 2100 employees, strong medical research

– Tampere University of Technology, 1850 researchers, “University of industry”

– VTT Technical Research Centre of Finland, 2800 employees

– The City of Tampere

– The region’s business community and companies

– Coordination: FinnMedi Oy

Page 8: Finn Medi Presentation study visit (Life Sciences Sector)

18.9.2014

© FinnMedi Oy 8

18.9.2014

© FinnMedi Oy 8

Life Science

Expertise in

Tampere

National capital in

human spareparts,

vaccines and

bio-ICT

Page 9: Finn Medi Presentation study visit (Life Sciences Sector)

FOCUSED R&D

Biomedical

engineering

• Biomaterials

• Implantable

devices

• Cell culturing

technolgy

BioICT

• Signal

processing

• Imaging

• Biosensors

Cell biology

• Stem cells

• Cell models

replacing

animal testing

• Vaccines

Page 10: Finn Medi Presentation study visit (Life Sciences Sector)

CROSS-SCIENTIFIC COLLABORATION

LEADS TO NEW THERAPIES

Eye related

diseases

• Preservative-free

eyedrop for

glaucoma treatment

• Stem cell therapy

for retinal pigment

epithelium

Autoimmune

diseases

• Vaccine against HIV

(phase I)

• Vaccine against

diabetes type 1

(preclinical)

• Rapid diagnostic test

for coeliac disease

Tissue repair and

regenerative

medicine

• Bioabsorbable

implants for tissue

repair

• Antibiotic releasing

biodegrable implant

• Bone deficiency

treatment with stem

cells

Page 11: Finn Medi Presentation study visit (Life Sciences Sector)

© FinnMedi Oy 11

Biomaterials and tissue engineering

Hospital

For

Advanced

Therapies

Finnish Tissue Bank,

FICAM

Spinoff companies

Biosensing

Competence

Center

Page 12: Finn Medi Presentation study visit (Life Sciences Sector)

Example of Research

Excellence BioMediTech:

world leader in stem cell based reconstructions of cranial bones

• 30 cases operated

• combination of

biomaterials and stem

cells differentiated from

subcutaneous fat

2 months post op 28 months post op

• Nearly 20 M€ project funding for Human Spare parts program (2011-2015)

•Development of tissue engineering products and supporting technologies

•Tekes, Academy of Finland, Council of Tampere Region, EU

Page 13: Finn Medi Presentation study visit (Life Sciences Sector)

FinnMedi Oy Bringing companies closer to clinics

FinnMedi is an internationally operating company

providing services related to research commercialization,

business development and clinical research

in the Life Sciences sector.

Page 14: Finn Medi Presentation study visit (Life Sciences Sector)

FinnMedi Oy Key Facts

• Founded 1995

• Personnel

• 17 permanent specialists/experts

• approximately 100 project

personnel annually

• Turnover 3,3 M€ (2012)

• Owners

• Pirkanmaa Hospital District

• City of Tampere

• Industrial Research Fund at

Tampere University of

Technology

• Tampere University Foundation

• Finnish Red Cross

Page 15: Finn Medi Presentation study visit (Life Sciences Sector)

FinnMedi Oy references

• the quantity of clinical trials over 500

• the volume of research grant agreements (e.g. EU) totally over

100 M€

• seeking of private and public funding for companies worth of

15 M€

• business idea evaluations over 300

• market and customer need analyses over 100

• business development projects for start-up and growth

companies over 50

• business coaching for researchers and inventors over 50

• regulatory and quality system consultancies over 30

Page 16: Finn Medi Presentation study visit (Life Sciences Sector)

FinnMedi

Services

Innovation

Clinical

Growth

• Idea Analysis

• Funding Expert

• Start-Up Coach

• Match Maker

• Business Analysis

• Business Coach

• Quality Expert

• Clinical Expert

• Investigator Recruitment

• Trial Documents &

Submissions

• Site Administration

Page 17: Finn Medi Presentation study visit (Life Sciences Sector)

The customers using our Innovation services

are research institutions, researchers and

other business or product idea owners.

Using our services, customers are able to

make the most efficient utilization of the

commercial potential of their research and

business idea.

Innovation • Idea Analysis

• Funding Expert

• Start-Up Coach

• Match Maker

Page 18: Finn Medi Presentation study visit (Life Sciences Sector)

Growth is a service entity intended for

growth companies to develop their

business and quality, regulatory and

clinical research processes.

Customers benefit through an improved

realisation of their growth plans.

Growth • Business Analysis

• Business Coach

• Quality Expert

• Clinical Expert

Page 19: Finn Medi Presentation study visit (Life Sciences Sector)

Clinical is a service package for companies focusing on

research and product development, offering clinical

research and product development in accordance with

applicable quality systems.

Using Clinical services, customers quickly and reliably

obtain the information they need to evaluate and improve

the safety, efficiency and functionality of their products.

In clinical research services our clients have direct

access to the investigators.

Clinical • Investigator Recruitment

• Trial Documents & Submissions

• Site Administration

Page 20: Finn Medi Presentation study visit (Life Sciences Sector)

18.9.2014

FinnMedi Oy 20

Clinical Trial Networks

FINN-

TRIALS

FINNMEDI

ECRIN/

Nordic Trial

Alliance

NATIONAL

HUBS

NATIONAL

HUBS

NATIONAL

HUBS

NATIONAL

HUBS

NATIONAL

HUBS

HELSINKI,

UNIVERSITY

HOSPITAL

DISTRICT

TURKU,

UNIVERSITY

HOSPITAL

DISTRICT

TAMPRERE,

UNIVERSITY

HOSPITAL

DISTRICT

KUOPIO,

UNIVERSITY

HOSPITAL

DISTRICT

OULU,

UNIVERSITY

HOSPITAL

DISTRICT

OTHER

RESEARCH

ORGANISATIONS

NATIONAL

HUB

Project

Tasks

Page 21: Finn Medi Presentation study visit (Life Sciences Sector)

Future

18.9.2014

© FinnMedi Oy 21

Page 22: Finn Medi Presentation study visit (Life Sciences Sector)

Gap between needs and resources.

New technologies for personalized and effective healthcare.

Raise of preventive care.

Value driven intervention, eHealth, on-line policlinics, crowd-sourcing, new combinations of services

Customer is decisionmaker.

More private funding to get health or wellness. Understanding motivational factors are nesessary to get people to take care of themselves.

Analysis

To deliver value is

the key.

Technology,

science and

competent people

are available.

Need for new

health ecosystem.

Tampere has

competence to be

one of the

integrators of new

treatments and

technologies.

International

partnering is

neccesary.

.

Action

Create innovation

platforms.

Active networking

and partnering.

Public-private

partnerhips and new

procurement

procedures.

Flagship projects of

change.

Measure impact of

actitivities to the

health

Co

nsu

me

rism

C

apab

itie

s b

y IC

T

Hig

h t

ech

low

co

st

Page 23: Finn Medi Presentation study visit (Life Sciences Sector)

Towards New Health Ecosystem

Breaking boundaries between organizations or

technologies

From Illness to

Health

’Health is state of fysical,

mental, and social

experience of each individual’

Self motivated care

Primary

care

’Specialized healthcare is less than 1 % of Life but ~75 % of health expenditure – and increasing’

Page 24: Finn Medi Presentation study visit (Life Sciences Sector)

Main Goals

• Increase health and wellness of citizens

• Generate new jobs into renewing health ecosystem. • Decrease pressure for public health and social services

• Create internationally competitive and attractive macro-

region for international investments

Cost

Benefit Benefit

Cost

Page 25: Finn Medi Presentation study visit (Life Sciences Sector)

Future

Health

Health Platforms

Advanced Care

International

Health

- Health management

- Innovative procurement

- Co-creation platforms

- Pilots

- Breaking boundaries

- Role models of change

- Revolutionary services

- The best know-how

- International co-creation

- Proactive localization

Page 26: Finn Medi Presentation study visit (Life Sciences Sector)

18.9.2014

© FinnMedi Oy 26

Technnology Park

1994-2012

Public hospital

-1994

Specialized Healthcare

BIOTECH Tecnology

Companies

Specialized

Healthcare

Wellness

Life Science

Specialized Healthcare

(+ Medical education and

clinical research)

Open and Networked Value Chain

International Lively Campus

2013-

KIBS

Selfcare

Services

New Customers

New players

Page 27: Finn Medi Presentation study visit (Life Sciences Sector)

Tampere university of applied sciences

Tampere university

Tampere university hospital

Green Care Park

> 500 M€ investments

5 000-10 000 sports clients

>10 000 students

>10 000 health professionals

>10 000 patients

Business

Park

Page 28: Finn Medi Presentation study visit (Life Sciences Sector)

Advanced Care – main topics

Personalized diag-

nostics

Predictive diagnostic

s

Primary Health Care

Rehabilitation

Specia-lized Care

Health registers

Persona-lized

pharma

Health Monito-

ring

Preven-tion

Crowd-sourcing

Eye

Body

Mind

Heart

Sports&

wellness

Page 29: Finn Medi Presentation study visit (Life Sciences Sector)

© FinnMedi Oy 29

Health and wellness services

Research, R&D and

–infrasructure

Education,

Conferences

Knowledge Intensive Business

Services

Fun, Sports & Leasure

Shops,

Living Breaking

boundaries,

DUI,

Co-Creation

leadership

and platforms

International

collaboration

Page 30: Finn Medi Presentation study visit (Life Sciences Sector)

Innovative tenders/

First customer

Co-creation

Outsourcing Defining

roles

Public procurement

Public Platform

Existing Services

Innovation

Page 31: Finn Medi Presentation study visit (Life Sciences Sector)

31 9/18/2014

Dimensions of Programmes and Change

Vision

Competences

Organization Projects and

activities

Collaboration Resources

Commitment Change-over

Page 32: Finn Medi Presentation study visit (Life Sciences Sector)

Principles of programmes

• Formulation of strategy

• Regional commitment => resources and support

• Focused technology transfer organization, FinnMedi Oy

• Continuous benchmarking

• Sisu and hard work

• Full-day middleman and planning service and seed money

for projects

• Professional technology transfer and business development

Page 33: Finn Medi Presentation study visit (Life Sciences Sector)

• Create strong strategy (focus)

• Middleman and clustering -methods are effective for Life Science

• Win-win networking attitude

• Organize also professional Business Development

• Fund projects more than institutions

•Trust yourself - 5 years is a very short time to for break-even !

What we have learned (programmes)

Page 34: Finn Medi Presentation study visit (Life Sciences Sector)

Thank you!

Contact

CEO Matti Eskola

[email protected]

+358 40 55 75355

www.finnmedi.com

18.9.2014

© FinnMedi Oy 34

Page 35: Finn Medi Presentation study visit (Life Sciences Sector)

Health Platforms

Advanced Care

International Health

Towards Healthies City in the World